Literature DB >> 31149126

THE INFLUENCE OF TOTAL OR SUB-TOTAL GASTRECTOMY ON GLUCOSE CONTROL IN DIABETIC AND NON-DIABETIC PATIENTS.

H Y Jin1, T S Park1, K A Lee1, Y H Baek1.   

Abstract

OBJECTIVE: Although bariatric surgery including gastrectomy has recently emerged as a useful treatment for type 2 DM with obesity, it is not clear whether gastrectomy itself can have beneficial effects on glucose metabolism. Therefore, in this study, we investigated changes in blood glucose in patients with and without diabetes who underwent gastrectomy.
METHODS: From Jan 2010 to May 2014, 77 patients with diabetes and 77 patients without diabetes who underwent gastrectomy at Chonbuk National University Hospital, South Korea, were included. We compared fasting plasma glucose levels and HbA1c value before and after gastric surgery.
RESULTS: After gastrectomy, 59 patients (38.3%) showed reduced fasting plasma glucose levels at the 1 year point, and 80 patients (51.9%) exhibited reduced fasting plasma glucose at 3 years, irrespective of their diabetes status. Among 77 patients with diabetes, decreased fasting plasma glucose was observed in 22 (28.6%) and 46 patients (59.7%) 1 and 3 years after gastrectomy, respectively. In patients who exhibited reduced fasting plasma glucose after gastrectomy, the degree of reduced glucose was as follows: 56.4±48.5 vs 23.2±16.1 mg/dL after 1 year, 58.3±52.3 vs 18.4±13.7 mg/dL after 3 years, in DM and non-DM patient respectively.
CONCLUSIONS: Although there was a significant drop in mean fasting glucose after gastrectomy, not all patients experienced a drop in fasting glucose. Gastrectomy did not show a consistent association with glucose reduction in patients with and without diabetes, and in about half of the patients, fasting plasma glucose levels increased after gastrectomy. Therefore, bariatric surgery including gastrectomy needs to be performed with care in diabetes, and glucose monitoring including oral glucose tolerance tests should be done for assessing or prediction of the glucose state after gastric surgery in non-DM patients.

Entities:  

Keywords:  HbA1c; bariatric surgery; fasting plasma glucose; gastrectomy

Year:  2016        PMID: 31149126      PMCID: PMC6535252          DOI: 10.4183/aeb.2016.423

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  26 in total

1.  The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.

Authors:  Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

2.  Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Authors:  R C Turner; C A Cull; V Frighi; R R Holman
Journal:  JAMA       Date:  1999-06-02       Impact factor: 56.272

3.  Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study.

Authors:  Branden G Duffey; Shaheen Alanee; Renato N Pedro; Bryan Hinck; Carly Kriedberg; Sayeed Ikramuddin; Todd Kellogg; Michelle Stessman; Angela Moeding; Manoj Monga
Journal:  J Am Coll Surg       Date:  2010-07       Impact factor: 6.113

4.  Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.

Authors:  S R Kashyap; S Daud; K R Kelly; A Gastaldelli; H Win; S Brethauer; J P Kirwan; P R Schauer
Journal:  Int J Obes (Lond)       Date:  2009-12-22       Impact factor: 5.095

5.  The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.

Authors:  Francesco Rubino; Michel Gagner; Paolo Gentileschi; Subhash Kini; Shoji Fukuyama; John Feng; Ed Diamond
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

Review 6.  Bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal:  JAMA       Date:  2004-10-13       Impact factor: 56.272

7.  Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2).

Authors:  Shashank S Shah; Jayashree S Todkar; Poonam S Shah; David E Cummings
Journal:  Surg Obes Relat Dis       Date:  2009-09-03       Impact factor: 4.734

8.  Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

Authors:  Blandine Laferrère; Julio Teixeira; James McGinty; Hao Tran; Joseph R Egger; Antonia Colarusso; Betty Kovack; Baani Bawa; Ninan Koshy; Hongchan Lee; Kimberly Yapp; Blanca Olivan
Journal:  J Clin Endocrinol Metab       Date:  2008-04-22       Impact factor: 5.958

9.  Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2.

Authors:  Wei-Jei Lee; Weu Wang; Yi-Chih Lee; Ming-Te Huang; Kong-Han Ser; Jung-Chien Chen
Journal:  J Gastrointest Surg       Date:  2007-10-16       Impact factor: 3.452

10.  Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.

Authors:  Philip R Schauer; Bartolome Burguera; Sayeed Ikramuddin; Dan Cottam; William Gourash; Giselle Hamad; George M Eid; Samer Mattar; Ramesh Ramanathan; Emma Barinas-Mitchel; R Harsha Rao; Lewis Kuller; David Kelley
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.